Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (GB:0JZU)
LSE:0JZU
McKesson (0JZU) Share Price & Analysis
1 Followers
0JZU Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$351.04 - $543.05
Previous Close$531.79
Volume529.00
Average Volume (3M)367.00
Market Cap
$69.91B
Enterprise Value$75.91B
Total Cash (Recent Filing)$1.98B
Total Debt (Recent Filing)$7.61B
Price to Earnings (P/E)24.1
Beta0.39
Next Earnings
May 07, 2024EPS Estimate
$6.36Next Dividend Ex-Date
Jun 03, 2024Dividend Yield0.45%
Share Statistics
EPS (TTM)22.06
Shares Outstanding131,408,286
10 Day Avg. Volume259
30 Day Avg. Volume367
Standard Deviation0.08
R-Squared0.26
Alpha0.00672
Financial Highlights & Ratios
Price to Book (P/B)-4.95
Price to Sales (P/S)0.08
Price to Cash Flow (P/CF)68.80
P/FCF Ratio108.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit6.14
Enterprise Value/Ebitda17.10
Forecast
1Y Price Target
$566.07Price Target Upside4.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
McKesson News
Bulls Say, Bears Say
Bulls Say
Contract WinMcKesson's recent win of the OptumRx contract is set to boost its operating momentum, as it adds significant drug volumes and earnings growth, enhancing its position as a strong large cap growth story.
Earnings GrowthThe contract with OptumRx is projected to contribute substantially to McKesson's revenue and operating profit, solidifying expectations for the company to surpass its long-term earnings growth targets.
Strategic PositioningMcKesson's transformation into a comprehensive healthcare services entity, with expanding roles in pharma distribution and oncology, positions it for a premium valuation similar to other leading healthcare companies.
Bears Say
Competitive LandscapeCompetitive displacement represents a key risk to what has been a relatively stable operating model for several years.
Financial UncertaintyThe lack of visibility into future impacts of the RAD bankruptcy is affecting the free cash flow guidance.
Product Growth ConcernsThe company is experiencing slowing growth in GLP-1s, which may contribute to a cautious outlook.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.49% Insiders
23.22% Mutual Funds
21.91% Other Institutional Investors
54.37% Public Companies and
Individual Investors
0JZU FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest share price was $351.04 and its highest was $543.05 in the past 12 months.
What is Mckesson Corp.’s market cap?
Currently, no data Available
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is May 07, 2024 which is in 11 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Feb 07, 2024. The company reported $7.74 earnings per share for the quarter, beating the consensus estimate of $7.042 by $0.698.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.62 which represents an annual dividend yield of 0.45%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is $6.36.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 131,408,280 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $7.74 in its last earnings report, beating expectations of $7.042. Following the earnings report the stock price went down -4.991%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Among the largest hedge funds holding Mckesson Corp.’s share is Viking Global Investors LP. It holds Mckesson Corp.’s shares valued at 1B.
---
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$566.07 (4.72% Upside)
$566.07 (4.72% Upside)
Blogger Sentiment
Bullish
GB:0JZU Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.74%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.10%
Trailing 12-Months
Company Description
Mckesson Corp.
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
---
0JZU Company Deck
---
0JZU Earnings Call
Q3 2024
0:00 / 0:00
---
0JZU Revenue Breakdown
86.96% U.S. Pharmaceutical
7.44% International
4.02% Medical-Surgical Solutions
1.59% Prescription Technology Solutions
---
0JZU Stock 12 Months Forecast
Average Price Target
$566.07
▲(4.72% Upside)
Technical Analysis
McKesson
―
Cardinal Health
―
CVS Health
―
Walgreens Boots Alliance
―
GoodRx Holdings
―
Best Analysts Covering 0JZU
1 Year
1 Year Success Rate
16/17 ratings generated profit
1 Year Average Return
+33.40%
reiterated a buy rating 5 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 94.12% of your transactions generating a profit, with an average return of +33.40% per trade.
---